|
Quotes & Info
|
| ABII > SEC Filings for ABII > Form 8-K on 12-Sep-2008 | All Recent SEC Filings |
12-Sep-2008
Change in Directors or Principal Officers
On September 9, 2008, the compensation committee of the board of directors of Abraxis BioScience, Inc. (the "Company") approved an increase to the annual base salary of Bruce Wendel, Executive Vice President of Corporate Operations and Development, to $425,000, effective as of April 1, 2008.
|
|